# FDA Inspection 1202777 - Octapharma Plasma Inc - April 07, 2023

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/f4384c86-7b93-447f-8620-13d02eea10e9
Source feed: FDA_Inspections

> FDA Inspection 1202777 for Octapharma Plasma Inc on April 07, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202777
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2023-04-07
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1202777 - 2023-04-07](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/935f0748-88ce-4876-95cd-76289a5bdd65)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/c684a11c-f806-4bf2-b095-66803f75e099

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d